Chris Varma, PhD, Partner Chris joined Flagship in 2007 as Partner and focuses primarily on Life Science investments. He came to Flagship with significant management experience in clinical development, regulatory strategy, business development, sales, and marketing.
Prior to Flagship, Chris was with Novartis Pharmaceuticals since 2004 where he served most recently as Director on the Tekturna (aliskiren) marketing team responsible for Medical Marketing, Medical Strategy, and Professional Promotions activities. Chris also oversaw Tekturna’s extensive clinical development programs, and played a key role in the FDA approval and successful commercial launch of Tekturna in early 2007. As a Director in Pharmaceutical Sales, Chris successfully drove his team to achieve the #1 ranking in the region. Previously at Novartis, Chris was a Director of Business Development & Licensing where he identified several in-licensing targets and was involved in key transactions. Prior to that, Chris focused on corporate strategy working directly with the Novartis Pharma CEO in Switzerland.
Before Novartis, Chris was a consultant for Millennium Pharmaceuticals working on projects in the Personalized Medicine Group. Before Millennium, Chris worked for the US Food and Drug Administration (FDA) in the Office of Combination Products. Early in his career he co-founded Epitrope Corporation, a company that developed server-side solutions for wireless telecom carriers.
Chris holds a Ph.D. in Biomedical Engineering from the Harvard-MIT Division of Health Sciences & Technology (HST), a M.S. in Management from Stanford University, and both a M.S. and B.S. in Computer Science from Stanford University.
|
